In BAAR, Switzerland, Evinova, a prominent AI-native clinical development technology company, has revealed a significant collaboration with Lothar Medical. This partnership aims to revolutionize the conducting of respiratory clinical trials on a global scale. The pact involves the integration of Evinova’s Unified Trial Solution with Lothar Medical’s respiratory devices. This integration is designed to enhance the connectivity and data availability throughout the trials, benefiting sponsors, trial sites, and patients. Evinova's Unified Trial Solution is a widely adopted, GxP-compliant platform.
